Black Diamond Therapeutics

BDTX

Market cap $125M

2.19 USD

+0.07

3.3%

At close Updated Mar 16, 4:00 PM EDT

Pre-market

After hours

2.17

-0.02

0.91%

1 day

3.3%

5 days

1.86%

1 month

-1.79%

3 months

-16.41%

6 months

-30.91%

Year to date

-12.05%

1 year

28.07%

5 years

-91.5%

10 years

-94.45%

About: Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

Employees: 54

Healthcare Biotechnology